# Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?

> **NCT01437371** · PHASE3 · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 35 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** - Angiotensin conversing enzyme inhibitors: enalapril, captopril, lisinopril, ramipril, trandolapril.

## Key facts

- **NCT ID:** NCT01437371
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2014-10-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01437371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01437371, "Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01437371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*